Six from MIT awarded 2026 Paul and Daisy Soros Fellowships for New Americans Top row, l-r: Denisse Córdova Carrizales, Ria Das, and Ronak Desai. Bottom row, l-r: Stacy Godfreey-Igwe ’22, Arya Rao, Ananthan Sadagopan ’24. Credits: Photos courtesy of the P.D. Soros Fellowships for New Americans. Changing the World, One Vaccine at a Time From machine learning to clinical care, graduating HST MD, and Harvard PhD student Anusha Nathan tackles infectious disease. Match Day 2026: How Harvard Medical School Students Chose Their Specialty Awaiting residency placements, graduates share excitement about chosen fields. New sensor sniffs out pneumonia on a patient’s breath The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions. IMES community profile: Jessica DeVilla Jessica DeVilla, HST MEMP PhD student in bioengineering, is working in two labs, one at Dana-Farber, one at Harvard, and she hopes her research into the efficacy of adoptive cellular therapies (ACT) will improve the treatment of cancer. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 … Next page Next Last page Last »
Six from MIT awarded 2026 Paul and Daisy Soros Fellowships for New Americans Top row, l-r: Denisse Córdova Carrizales, Ria Das, and Ronak Desai. Bottom row, l-r: Stacy Godfreey-Igwe ’22, Arya Rao, Ananthan Sadagopan ’24. Credits: Photos courtesy of the P.D. Soros Fellowships for New Americans.
Changing the World, One Vaccine at a Time From machine learning to clinical care, graduating HST MD, and Harvard PhD student Anusha Nathan tackles infectious disease.
Match Day 2026: How Harvard Medical School Students Chose Their Specialty Awaiting residency placements, graduates share excitement about chosen fields.
New sensor sniffs out pneumonia on a patient’s breath The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.
IMES community profile: Jessica DeVilla Jessica DeVilla, HST MEMP PhD student in bioengineering, is working in two labs, one at Dana-Farber, one at Harvard, and she hopes her research into the efficacy of adoptive cellular therapies (ACT) will improve the treatment of cancer.
